Literature DB >> 10899805

Appetitive behavior, compulsivity, and neurochemistry in Prader-Willi syndrome.

A Dimitropoulos1, I D Feurer, E Roof, W Stone, M G Butler, J Sutcliffe, T Thompson.   

Abstract

Advances in genetic research have led to an increased understanding of genotype-phenotype relationships. Excessive eating and weight gain characteristic of Prader-Willi syndrome (PWS) have been the understandable focus of much of the research. The intense preoccupation with food, lack of satiation, and incessant food seeking are among the most striking features of PWS. It has become increasingly clear that the behavioral phenotype of PWS also includes symptoms similar to obsessive compulsive disorder, which in all probability interact with the incessant hunger and lack of satiation to engender the intense preoccupation and food seeking behavior that is characteristic of this disorder. Several lines of evidence suggest that genetic material on chromosome 15 may alter synthesis, release, metabolism, binding, intrinsic activity, or reuptake of specific neurotransmitters, or alter the receptor numbers and/or distribution involved in modulating feeding. Among the likely candidates are GABAnergic, serotonergic, and neuropeptidergic mechanisms. This review summarizes what is known about the appetitive behavior and compulsivity in PWS and discusses the possible mechanisms underlying these behaviors. MRDD Research Reviews 2000;6:125-130. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899805      PMCID: PMC6777566          DOI: 10.1002/1098-2779(2000)6:2<125::AID-MRDD6>3.0.CO;2-T

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN: 1080-4013


  47 in total

1.  Cerebrospinal fluid levels of oxytocin in Prader-Willi syndrome: a preliminary report.

Authors:  A Martin; M State; G M Anderson; W M Kaye; J M Hanchett; C W McConaha; W G North; J F Leckman
Journal:  Biol Psychiatry       Date:  1998-12-15       Impact factor: 13.382

2.  Prader-Willi syndrome. A resumé of 32 cases including an instance of affected first cousins, one of whom is of normal stature and intelligence.

Authors:  B D Hall; D W Smith
Journal:  J Pediatr       Date:  1972-08       Impact factor: 4.406

3.  Fenfluramine in Prader-Willi syndrome: a double blind, placebo controlled trial.

Authors:  M Selikowitz; J Sunman; A Pendergast; S Wright
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

Review 4.  Prader-Willi syndrome.

Authors:  S B Cassidy
Journal:  Curr Probl Pediatr       Date:  1984-01

5.  Effects of repeated administration of serotonergic agonists on diet selection and body weight in rats.

Authors:  S Q Luo; E T Li
Journal:  Pharmacol Biochem Behav       Date:  1991-03       Impact factor: 3.533

6.  Obsessive-compulsive symptoms in Prader-Willi and "Prader-Willi-Like" patients.

Authors:  M W State; E M Dykens; B Rosner; A Martin; B H King
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-03       Impact factor: 8.829

7.  Self-injurious behavior and Prader-Willi syndrome: behavioral forms and body locations.

Authors:  F J Symons; M G Butler; M D Sanders; I D Feurer; T Thompson
Journal:  Am J Ment Retard       Date:  1999-05

8.  Localization of the gene encoding the GABAA receptor beta 3 subunit to the Angelman/Prader-Willi region of human chromosome 15.

Authors:  J Wagstaff; J H Knoll; J Fleming; E F Kirkness; A Martin-Gallardo; F Greenberg; J M Graham; J Menninger; D Ward; J C Venter
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

Review 9.  Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder.

Authors:  S Saxena; A L Brody; J M Schwartz; L R Baxter
Journal:  Br J Psychiatry Suppl       Date:  1998

10.  Characteristics of abnormal food-intake patterns in children with Prader-Willi syndrome and study of effects of naloxone.

Authors:  W B Zipf; G G Berntson
Journal:  Am J Clin Nutr       Date:  1987-08       Impact factor: 7.045

View more
  10 in total

Review 1.  Experimental analyses of gene-brain-behavior relations: some notes on their application.

Authors:  C H Kennedy; M Caruso; T Thompson
Journal:  J Appl Behav Anal       Date:  2001

Review 2.  Mechanisms for AgRP neuron-mediated regulation of appetitive behaviors in rodents.

Authors:  M Alex Thomas; Bingzhong Xue
Journal:  Physiol Behav       Date:  2017-10-12

Review 3.  Epigenetic aberrations in human pluripotent stem cells.

Authors:  Shiran Bar; Nissim Benvenisty
Journal:  EMBO J       Date:  2019-05-14       Impact factor: 11.598

4.  Methylation-specific multiplex ligation-dependent probe amplification and identification of deletion genetic subtypes in Prader-Willi syndrome.

Authors:  Rebecca S Henkhaus; Soo-Jeong Kim; Virginia E Kimonis; June-Anne Gold; Elisabeth M Dykens; Daniel J Driscoll; Merlin G Butler
Journal:  Genet Test Mol Biomarkers       Date:  2011-10-06

5.  A measure of food seeking in individuals with Prader-Willi syndrome.

Authors:  J Young; J Zarcone; L Holsen; M C Anderson; S Hall; D Richman; M G Butler; T Thompson
Journal:  J Intellect Disabil Res       Date:  2006-01

Review 6.  Pharmacotherapy of Disruptive Behaviors in Children with Intellectual Disabilities.

Authors:  Gabrielle E Hodgins; Kristen Winsor; Jarrett Barnhill
Journal:  Paediatr Drugs       Date:  2022-07-04       Impact factor: 3.930

Review 7.  Biological, Behavioral, and Ethical Considerations of Prader-Willi Syndrome: A Primer for Behavior Analysts.

Authors:  Danielle Kennedy; Halle Marten; Clare O'Sullivan; Rocco Catrone
Journal:  Behav Anal Pract       Date:  2021-07-08

Review 8.  Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

Authors:  S M Francis; A Sagar; T Levin-Decanini; W Liu; C S Carter; S Jacob
Journal:  Brain Res       Date:  2014-01-22       Impact factor: 3.252

9.  TPH2 polymorphisms and expression in Prader-Willi syndrome subjects with differing genetic subtypes.

Authors:  Rebecca S Henkhaus; Douglas C Bittel; Merlin G Butler
Journal:  J Neurodev Disord       Date:  2010-05-21       Impact factor: 4.025

10.  Caralluma Fimbriata Supplementation Improves the Appetite Behavior of Children and Adolescents with Prader-Willi Syndrome.

Authors:  Joanne L Griggs; Xiao Q Su; Michael L Mathai
Journal:  N Am J Med Sci       Date:  2015-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.